US · Healthcare

Adial Pharmaceuticals Inc (ADIL)

Biotechnology

Adial Pharmaceuticals Inc (ADIL) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ADIL

P/E ratio

25.00

Adial Pharmaceuticals Inc (ADIL) — FAQ

What is ADIL's P/E ratio?

The price-to-earnings (P/E) ratio for Adial Pharmaceuticals Inc (ADIL) is 25.00 (data as of 2026-05-23).

Does Adial Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Adial Pharmaceuticals Inc (ADIL). Check the MyAverix Finance app for the latest dividend data.

What sector is Adial Pharmaceuticals Inc in?

Adial Pharmaceuticals Inc (ADIL) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ADIL listed on?

ADIL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)